ID21014A - Modifikasi kristal dari zat farmasi - Google Patents

Modifikasi kristal dari zat farmasi

Info

Publication number
ID21014A
ID21014A IDW980066D ID980066D ID21014A ID 21014 A ID21014 A ID 21014A ID W980066 D IDW980066 D ID W980066D ID 980066 D ID980066 D ID 980066D ID 21014 A ID21014 A ID 21014A
Authority
ID
Indonesia
Prior art keywords
pharmaceuticals
crystal modification
crystal
modification
Prior art date
Application number
IDW980066D
Other languages
English (en)
Indonesian (id)
Inventor
Robert Portmann
Urs Christoph Hofmeier
Andreas Burkhard
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID21014(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ID21014A publication Critical patent/ID21014A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
IDW980066D 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi ID21014A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10

Publications (1)

Publication Number Publication Date
ID21014A true ID21014A (id) 1999-04-08

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
IDW980066D ID21014A (id) 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi
IDW980065D ID27660A (id) 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi

Family Applications After (1)

Application Number Title Priority Date Filing Date
IDW980065D ID27660A (id) 1997-06-10 1998-06-08 Modifikasi kristal dari zat farmasi

Country Status (37)

Country Link
US (6) US6740669B1 (nl)
EP (2) EP0994863B1 (nl)
JP (2) JP3672575B2 (nl)
KR (2) KR100409168B1 (nl)
CN (3) CN1159300C (nl)
AR (4) AR012946A1 (nl)
AT (2) ATE237599T1 (nl)
AU (2) AU725517B2 (nl)
BR (2) BR9804947A (nl)
CA (3) CA2614926C (nl)
CO (2) CO4940448A1 (nl)
CY (1) CY2007014I1 (nl)
CZ (2) CZ292481B6 (nl)
DE (3) DE69811500T2 (nl)
DK (2) DK0994864T3 (nl)
ES (2) ES2197485T3 (nl)
FR (1) FR07C0037I2 (nl)
HK (3) HK1028242A1 (nl)
HU (2) HU226107B1 (nl)
ID (2) ID21014A (nl)
IL (2) IL125732A (nl)
LU (1) LU91345I2 (nl)
MY (2) MY125854A (nl)
NL (1) NL300284I2 (nl)
NO (2) NO329315B1 (nl)
NZ (2) NZ331370A (nl)
PE (2) PE80999A1 (nl)
PL (2) PL192114B1 (nl)
PT (1) PT994864E (nl)
RU (2) RU2194041C2 (nl)
SI (2) SI0994864T1 (nl)
SK (2) SK283734B6 (nl)
TR (2) TR199801631T1 (nl)
TW (2) TW526195B (nl)
UY (1) UY25844A1 (nl)
WO (2) WO1998056773A1 (nl)
ZA (2) ZA984967B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
ATE390425T1 (de) * 2002-05-31 2008-04-15 Schering Corp Xanthin-phosphodiesterase-v-hemmer polymorphe
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
CA2736703A1 (en) * 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
RU2594155C2 (ru) * 2009-09-04 2016-08-10 Тэктикал Терапеутикс, Инк Новые композиции и способы получения 5-амино- или замещенных амино-1,2,3-триазолов и триазол-оротатных композиций
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
EP2727914A1 (en) * 2010-04-30 2014-05-07 Laboratorios Lesvi, S.L. Polymorph of 1-(2,6-difluorobenzyl)-1h-1,2,3-triazole-carboxamide
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
WO2014013511A2 (en) * 2012-07-20 2014-01-23 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) * 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
JPH04506967A (ja) 1989-07-27 1992-12-03 ジー．ディー．サール　アンド　カンパニー 高血圧症治療用腎選択性生成物
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
DE69132340T2 (de) 1990-11-06 2001-02-08 Yamanouchi Pharma Co Ltd Kondensiertes pyrazinderivat
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
US6096779A (en) 1995-02-22 2000-08-01 Hoechst Pharmaceuticals & Chemicals K.K. Amorphous piretanide, piretanide polymorphs, process for their preparation and their use
WO1998002423A1 (en) * 1996-07-11 1998-01-22 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW526195B (en) * 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use

Also Published As

Publication number Publication date
PE80999A1 (es) 1999-09-06
LU91345I2 (fr) 2007-09-04
DK0994864T3 (da) 2003-07-21
SI0994864T1 (en) 2003-10-31
CA2614926A1 (en) 1998-12-17
DE69813560T2 (de) 2004-02-05
UY25844A1 (es) 2001-08-27
JP3672574B2 (ja) 2005-07-20
TR199801630T1 (xx) 1999-06-21
CN1159300C (zh) 2004-07-28
ATE237599T1 (de) 2003-05-15
LU91345I9 (nl) 2018-12-31
HK1028031A1 (en) 2001-02-02
CN1298708C (zh) 2007-02-07
CA2256015C (en) 2008-06-03
AU725517B2 (en) 2000-10-12
DE69811500T2 (de) 2004-04-01
US6455556B2 (en) 2002-09-24
US20060116520A1 (en) 2006-06-01
CZ253398A3 (cs) 1999-04-14
ES2197485T3 (es) 2004-01-01
EP0994864A1 (en) 2000-04-26
CN1132820C (zh) 2003-12-31
PL330798A1 (en) 1999-06-07
RU2198167C2 (ru) 2003-02-10
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
JP3672575B2 (ja) 2005-07-20
HK1028242A1 (en) 2001-02-09
TR199801631T1 (xx) 1999-06-21
CO4940452A1 (es) 2000-07-24
PL191943B1 (pl) 2006-07-31
IL125732A0 (en) 1999-04-11
SK109398A3 (en) 1998-12-02
CA2614926C (en) 2010-02-09
US20010037029A1 (en) 2001-11-01
FR07C0037I1 (nl) 2007-08-17
AU8437298A (en) 1998-12-30
NO329314B1 (no) 2010-09-27
US20030125568A1 (en) 2003-07-03
US6740669B1 (en) 2004-05-25
JP2000516259A (ja) 2000-12-05
DK0994863T3 (da) 2003-05-26
TW526195B (en) 2003-04-01
NO983666L (no) 1998-12-17
NO983666D0 (no) 1998-08-11
SK109498A3 (en) 1998-12-02
CZ292481B6 (cs) 2003-09-17
HUP0002113A3 (en) 2002-09-30
KR19990087836A (ko) 1999-12-27
WO1998056772A1 (en) 1998-12-17
NZ331371A (en) 2000-08-25
SI0994863T1 (en) 2003-08-31
ZA984966B (en) 1999-01-11
BR9804947A (pt) 1999-08-24
DE69811500D1 (de) 2003-03-27
PE79799A1 (es) 1999-09-03
IL125733A0 (en) 1999-04-11
NO983667L (no) 1998-12-17
ATE232852T1 (de) 2003-03-15
CY2007014I2 (el) 2009-11-04
TW403740B (en) 2000-09-01
EP0994863A1 (en) 2000-04-26
AU8437198A (en) 1998-12-30
CA2256013A1 (en) 1998-12-17
PL330764A1 (en) 1999-05-24
EP0994863B1 (en) 2003-02-19
CZ253498A3 (cs) 1999-04-14
AR061005A2 (es) 2008-07-30
IL125733A (en) 2002-12-01
HUP0000798A2 (hu) 2000-10-30
CY2007014I1 (el) 2009-11-04
RU2194041C2 (ru) 2002-12-10
ES2192779T3 (es) 2003-10-16
AR061004A2 (es) 2008-07-30
CO4940448A1 (es) 2000-07-24
HUP0000798A3 (en) 2000-10-30
HK1028241A1 (en) 2001-02-09
KR100409168B1 (ko) 2004-01-31
PT994864E (pt) 2003-07-31
HU225153B1 (en) 2006-07-28
CZ292260B6 (cs) 2003-08-13
CN1217716A (zh) 1999-05-26
AU725528B2 (en) 2000-10-12
DE122007000051I2 (de) 2009-02-19
NO329315B1 (no) 2010-09-27
US7750028B2 (en) 2010-07-06
KR100425656B1 (ko) 2004-05-17
AR012945A1 (es) 2000-11-22
BR9804946A (pt) 1999-08-24
EP0994864B1 (en) 2003-04-16
CA2256015A1 (en) 1998-12-17
JP2000516258A (ja) 2000-12-05
CN1572789A (zh) 2005-02-02
US20100310655A1 (en) 2010-12-09
IL125732A (en) 2002-12-01
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
ZA984967B (en) 1999-01-11
FR07C0037I2 (nl) 2008-05-16
SK283685B6 (sk) 2003-12-02
PL192114B1 (pl) 2006-08-31
AR012946A1 (es) 2000-11-22
ID27660A (id) 2001-04-19
DE122007000051I1 (de) 2007-11-08
HUP0002113A2 (hu) 2001-02-28
NZ331370A (en) 2000-08-25
MY125854A (en) 2006-08-30
KR19990087835A (ko) 1999-12-27
NL300284I2 (nl) 2007-11-01
HU226107B1 (en) 2008-04-28
DE69813560D1 (de) 2003-05-22
MY120156A (en) 2005-09-30
CA2256013C (en) 2007-10-16
US8076362B2 (en) 2011-12-13
CN1259127A (zh) 2000-07-05
US20040167186A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
ID25660A (id) Teripatide kristal
ID28779A (id) BENTUK-BENTUK KRISTAL DARI EtO2C-CH2-(R)CgL-Aze-Pab-OH
ID25534A (id) Glucagon-seperti kristal peptida-1
DE69835976D1 (de) Polarisationsunabhängiger optischer Phasenmodulator
DK1445259T3 (da) Anvendelse af krystalformer for 2-methyl-thieno-benzodiazepin
ID25629A (id) AMINA BISIKLIK (Pecahan dari P-961362)
DE69528095T2 (de) Optischer, räumlicher Flüssigkristall-Phasenmodulator
ID20954A (id) Aparat tampilan kristal cair tipe-projeksi
DE69637044D1 (de) Mittel zur orientierung von flüssigkristallen
NL300284I2 (nl) Kristalmodificatie van
NO331016B1 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat
FI962932A (fi) Ankkuriproteiinifunktion modulaattoreita
DE69833534D1 (de) Flüssigkristallfarbprojektor
ATE196764T1 (de) Kristallform von 5-methylisoxazol-4-carbonsäure- (4-trifluormethyl)-anilid
NO980287L (no) Optiske enkeltsidebÕndsmodulatorer
ID19410A (id) Zat pembantu pemutihan (pecahan dari p-940903)
DE69526586D1 (de) Linsenkapselspreizer
DK0966293T3 (da) Lægemiddel til fremme af sårheling indeholdende thrombocytter
DE69800559D1 (de) Ferrielektrische Flüssigkristallverbindung
DE69801549D1 (de) Schwalbenschwanzförmige Flüssigkristallverbindung
DE69823908D1 (de) Einkristallziehvorrichtung
NO980078D0 (no) Drift av optisk modulator
ID27596A (id) Bentuk paroksetina kristal
ID22787A (id) Nitro-benzamida berguna sebagai zat anti - arritimia
ID26290A (id) Bentuk-bentuk kristal dari is [1alfa(2s*, 3r*), 9alfa] 6,10-diokso-n-(2-etoksi-5-okso-tetrahidro-3-furanil)-9 [[ (1-isokuinolil)karbonil] amino]oktahidro-6h-piridazino [1,2-a] [1,2] diazepin-1-karboksamida